Chemokine CX3CL1 has potential anti-fibrosis effect in mouse liver fibrosis

Objective To explore the effect and mechanism of chemokine CX3CL1 on mouse liver fibrosis model. Methods C57BL/6 mice were randomly divided into CCl-4 model group and normal control group with 8 animals in each group. The model group was injected with 10% CCl-4 intra peritoneally for 6 weeks. After...

Full description

Bibliographic Details
Main Author: CHENG Qi, LI Ning, YU Kangkang, SHI Guangfeng
Format: Article
Language:zho
Published: Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College. 2023-12-01
Series:Jichu yixue yu linchuang
Subjects:
Online Access:http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/1001-6325-2023-43-12-1792.pdf
_version_ 1827391315820675072
author CHENG Qi, LI Ning, YU Kangkang, SHI Guangfeng
author_facet CHENG Qi, LI Ning, YU Kangkang, SHI Guangfeng
author_sort CHENG Qi, LI Ning, YU Kangkang, SHI Guangfeng
collection DOAJ
description Objective To explore the effect and mechanism of chemokine CX3CL1 on mouse liver fibrosis model. Methods C57BL/6 mice were randomly divided into CCl-4 model group and normal control group with 8 animals in each group. The model group was injected with 10% CCl-4 intra peritoneally for 6 weeks. After 6 weeks, the mice were sacrificed, and the pathological changes of the mouse liver were observed by HE staining. The level of CX3CL1 in peripheral blood of the mice was measured, and the expression level of CX3CL1 mRNA in the liver tissue of the mice was detected. In addition, in order to explore the mechanism of CX3CL1, the level of IFN-γ in mouse serum was detected as well. Results After the 6-week modeling, the liver pathology microscopy showed a successful modeling of liver fibrosis. The serum CX3CL1 level and liver tissue CX3CL1 expression in the model group were found to be significantly up-regulated, which suggested a potential impact on the pathogenesis of liver fibrosis. In addition, the level of IFN-γ in the serum of mice in the model group increased significantly. Conclusions CX3CL1 is related to liver fibrosis in mice, and its mechanism might be explained by promoting the production of IFN-γ so to prevent liver fibrosis.
first_indexed 2024-03-08T17:08:31Z
format Article
id doaj.art-101477d6d90240a8b8eb0f72595fc18e
institution Directory Open Access Journal
issn 1001-6325
language zho
last_indexed 2024-03-08T17:08:31Z
publishDate 2023-12-01
publisher Institute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College.
record_format Article
series Jichu yixue yu linchuang
spelling doaj.art-101477d6d90240a8b8eb0f72595fc18e2024-01-04T01:10:35ZzhoInstitute of Basic Medical Sciences and Peking Union Medical College Hospital, Chinese Academy of Medical Sciences / Peking Union Medical College.Jichu yixue yu linchuang1001-63252023-12-0143121792179510.16352/j.issn.1001-6325.2023.12.1792Chemokine CX3CL1 has potential anti-fibrosis effect in mouse liver fibrosisCHENG Qi, LI Ning, YU Kangkang, SHI Guangfeng0Department of Infectious Diseases, Huashan Hospital, Fudan University, Shanghai 200040, ChinaObjective To explore the effect and mechanism of chemokine CX3CL1 on mouse liver fibrosis model. Methods C57BL/6 mice were randomly divided into CCl-4 model group and normal control group with 8 animals in each group. The model group was injected with 10% CCl-4 intra peritoneally for 6 weeks. After 6 weeks, the mice were sacrificed, and the pathological changes of the mouse liver were observed by HE staining. The level of CX3CL1 in peripheral blood of the mice was measured, and the expression level of CX3CL1 mRNA in the liver tissue of the mice was detected. In addition, in order to explore the mechanism of CX3CL1, the level of IFN-γ in mouse serum was detected as well. Results After the 6-week modeling, the liver pathology microscopy showed a successful modeling of liver fibrosis. The serum CX3CL1 level and liver tissue CX3CL1 expression in the model group were found to be significantly up-regulated, which suggested a potential impact on the pathogenesis of liver fibrosis. In addition, the level of IFN-γ in the serum of mice in the model group increased significantly. Conclusions CX3CL1 is related to liver fibrosis in mice, and its mechanism might be explained by promoting the production of IFN-γ so to prevent liver fibrosis.http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/1001-6325-2023-43-12-1792.pdfchemokine|cx3cl1|liver fibrosis|interferon-γ
spellingShingle CHENG Qi, LI Ning, YU Kangkang, SHI Guangfeng
Chemokine CX3CL1 has potential anti-fibrosis effect in mouse liver fibrosis
Jichu yixue yu linchuang
chemokine|cx3cl1|liver fibrosis|interferon-γ
title Chemokine CX3CL1 has potential anti-fibrosis effect in mouse liver fibrosis
title_full Chemokine CX3CL1 has potential anti-fibrosis effect in mouse liver fibrosis
title_fullStr Chemokine CX3CL1 has potential anti-fibrosis effect in mouse liver fibrosis
title_full_unstemmed Chemokine CX3CL1 has potential anti-fibrosis effect in mouse liver fibrosis
title_short Chemokine CX3CL1 has potential anti-fibrosis effect in mouse liver fibrosis
title_sort chemokine cx3cl1 has potential anti fibrosis effect in mouse liver fibrosis
topic chemokine|cx3cl1|liver fibrosis|interferon-γ
url http://journal11.magtechjournal.com/Jwk_jcyxylc/fileup/1001-6325/PDF/1001-6325-2023-43-12-1792.pdf
work_keys_str_mv AT chengqiliningyukangkangshiguangfeng chemokinecx3cl1haspotentialantifibrosiseffectinmouseliverfibrosis